Endonovo Therapeutics, Inc. (ENDV)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
At close: Oct 19, 2026
Endonovo Therapeutics Market Cap
Endonovo Therapeutics has a market cap or net worth of $90.38 thousand as of October 20, 2026. It is the 51,191st most valuable company in the world and the 7,296th biggest in the United States. Its market cap has decreased by 25.10% in one year.
Market Cap
90.38K
Enterprise Value
n/a
Revenue
255.72K
Global Rank
Country Rank
#7,296 United States
PE Ratio
n/a
ChartMarket Cap Chart
Since February 20, 2013, Endonovo Therapeutics's market cap has increased from 78.90K to 90.38K, an increase of 14.55%. That is a compound annual growth rate of 1.00%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 19, 2026 | 180.76K | - |
| Dec 31, 2025 | 180.76K | -16.91% |
| Dec 31, 2024 | 217.55K | -92.16% |
| Dec 29, 2023 | 2.77M | -20.72% |
| Dec 30, 2022 | 3.50M | 211.37% |
| Dec 31, 2021 | 1.12M | 127.79% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Nextel Medical | 288.95K |
| Ampio Pharmaceuticals | 207.88K |
| CNBX Pharmaceuticals | 192.58K |
| Regen BioPharma | 167.53K |
| Sigyn Therapeutics | 159.54K |
| Innovation Pharmaceuticals | 158.63K |
| U.S. Stem Cell | 132.30K |
| Ocean Biomedical | 116.18K |